© 1998 American Heart Association, Inc.
Original Contributions |
Animal Model That Mimics Atherosclerotic Plaque Rupture
From the Department of Vascular and Cardiac Diseases, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company (M.D.R., G.W.H., D.W.B., D.G., J.A.K., M.J.R.), and the Department of Pathology, University of Michigan (C.W.W., J.-S.K, D.G.), Ann Arbor, Mich.
Correspondence to Dr Mark D. Rekhter, Vascular and Cardiac Diseases, Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Rd, Ann Arbor, MI 48105. E-mail REKHTEM{at}aa.wl.com
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Abstract—Atherosclerotic plaque rupture is the main cause of coronary thrombosis and myocardial infarcts. Currently, there is no animal model of plaque disruption. We have developed a rabbit model in which an atherosclerotic plaque can be ruptured at will after an inflatable balloon becomes embedded into the plaque. Furthermore, the pressure needed to inflate the plaque-covered balloon may be an index of overall plaque mechanical strength. The thoracic aorta of hypercholesterolemic rabbits underwent mechanical removal of endothelial cells, and then a specially designed balloon catheter was introduced into the lumen of the thoracic aorta. As early as 1 month after catheter placement, atherosclerotic plaque formed around the indwelling balloon. The plaques were reminiscent of human atherosclerotic lesions, in terms of cellular composition, patterns of lipid accumulation, and growth characteristics. Intraplaque balloons were inflated both ex vivo and in vivo, leading to plaque fissuring. The ex vivo strategy is designed to measure the mechanical strength of the surrounding plaque, while the in vivo scenario permits an analysis of the plaque rupture consequences, eg, thrombosis. In addition, our model allows local delivery of various substances into the plaque. The model can be used to study the pathogenesis of plaque instability and to design plaque stabilization therapy.
Key Words: atherosclerosis • catheter • plaque • rupture • thrombus
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The abrupt closure of an artery by an occlusive thrombus is the main cause of myocardial infarcts and other thrombotic sequelae of atherosclerosis. This thrombosis is often associated with a fissure that develops in the underlying atherosclerotic plaque.1 2 3 4 5 6 Therapy that prevents plaque rupture may significantly decrease the incidence of heart attack and stroke, while treatment that reduces blood clot formation associated with plaque disruption may reduce mortality after such catastrophic events. Currently, there is no specific therapy for plaque rupture.2 Research on the mechanisms of plaque destabilization and development of "stabilization therapy" have been hampered by lack of an appropriate animal model.6 Our aim was to develop an animal model of atherosclerosis, in which the plaque could be ruptured at will under controlled conditions.
Atherosclerotic plaque rupture occurs as a result of interactions between external mechanical triggers and vulnerable regions of the plaque, when forces acting on the plaque exceed its tensile strength.7 8 9 The exact nature of these external forces is still unknown, thus making it difficult to design specific treatments to prevent plaque rupture. However, plaque tissue properties undoubtedly determine the mechanical strength/vulnerability of plaques and may be realistic targets for therapeutic intervention. Therefore, we focused on designing a model to evaluate plaque mechanical strength/vulnerability characteristics. The admittedly important problem of clinically relevant triggers of plaque disruption10 remains to be addressed.
Our experimental approach was based on the hypothesis that an atherosclerotic plaque can be ruptured at will if an inflatable balloon is embedded into the plaque. Furthermore, the pressure needed to inflate the plaque-covered balloon may be an index of overall plaque mechanical strength. We have been able to demonstrate that balloons can be inflated either ex vivo or in vivo. Our ex vivo experiments were designed to measure mechanical strength of the surrounding plaque, while the in vivo scenario permits an analysis of plaque rupture sequelae (eg, thrombosis).
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Reproducible plaque formation on the balloon surface is essential. Our preliminary results (data not shown) revealed 3 key elements necessary and sufficient for the growth of balloon-associated plaques: (1) smooth muscle cell (SMC) migration from media into intima; (2) stable direct contact between arterial wall and balloon surface, enabling vessel-derived cells to adhere to the balloon surface; and (3) balloon surface properties that facilitate SMC migration and proliferation. Described below are the experimental procedures that meet the requirements for balloon-associated plaque formation (specific catheter preparation, vessel preparation, and placement of the catheter into the vessel). Also described are the balloon inflation procedures used to cause plaque disruption.
Diet
All procedures that used animals were conducted in compliance
with state and federal laws, as well as guidelines established by the
Parke-Davis Animal Care and Use Committee. Our preliminary observations
(data not shown) indicated that cholesterol feeding is not
crucial for the induction of balloon-associated tissue growth. However,
cholesterol feeding results in plaque lipid accumulation, a
feature reminiscent of human atherosclerotic lesions. Male New Zealand
White rabbits (Covance, Denver, Pa, weighing 2.5 to 3.0 kg) were
meal-fed a rabbit chow diet supplemented with 0.5%
cholesterol, 3% peanut oil, and 3% coconut oil. The diet
was started 1 week before surgery and continued until the end of the
experiments. Plasma cholesterol was determined using the
Abbot VP analyzer. At the end of the experiment (5 weeks on the
diet), the average plasma cholesterol level was
721.6±116.7 mg/dL.
Catheter and Balloon Surface Preparation
For lesions to form, the balloon must have constant direct
contact with the injured arterial wall, facilitating SMC
migration from the artery to the balloon surface. To assure direct
contact, we used a custom-designed catheter (NuMed Inc) with a C-shaped
tip and an expandable latex balloon situated on the curved segment
(Figure 1A
). Because the width of the
curvature slightly exceeded the diameter of the artery, the balloon was
firmly pressed against the arterial wall (Figure 1B). The
catheter had 3 ports and channels; 1 to accommodate a guide wire, a
second for balloon inflation, and a third to deliver biologically
active agents locally into the lesion (Figure 1A).
|
To provide a substrate that supports cell migration and growth, a small
segment of vein was placed over the balloon (Figure 2A). Rabbits were anesthetized by
the concurrent intramuscular injection of xylazine, ketamine,
and atropine in doses of 2, 35, and 0.062 mg/kg, respectively.
Anesthesia was maintained with isoflurane gas (0.25% to
0.5%) using a mask technique. A skin incision was made on the neck,
and the left jugular vein was surgically exposed. The vein segment was
isolated by 2 ties, frozen using a metal applicator cooled in liquid
nitrogen, and then allowed to thaw. It has been previously shown that
freezing effectively kills all the cells yet preserves the
extracellular matrix composition, thus providing a good substrate for
further SMC and endothelial cell migration and
proliferation.11 The C-shaped indwelling catheter
was inserted into the isolated vein segment through a small incision
and advanced, so the vein segment covered the balloon as well as the
infusion outlet situated proximal to the balloon. The frozen vein
segment was then attached to the catheter by 2 ties and separated from
the rest of the vein. As a result, a vein-derived fibrous bag was
sealed over the expandable balloon and infusion outlet. This tissue (1)
provided a collagen matrix that facilitated plaque formation and (2)
delimited a space between the plaque and balloon catheter into which
biologically active material could be placed using an infusion
port.
|
Catheter Placement
To induce SMC migration, the thoracic aorta was injured with an
embolectomy balloon catheter (Figure 2B
). First, a guide catheter (4.1F
cerebral catheter, Cook Inc) was advanced through a carotid arteriotomy
to the descendent thoracic aorta under fluoroscopic guidance; then a
guide wire (0.014-inch Sceptor "EnTre-Style," Scimed Life Systems,
Inc) was passed into the aorta through the guide catheter. The guide
catheter was then removed, leaving the guide wire in place. Next a 4F
embolectomy catheter (Baxter) was introduced over the guide wire with
the tip placed at the level of diaphragm. The balloon was inflated and
then pulled back to remove endothelial cells in the
thoracic aorta. This process was repeated 3 times, and the catheter was
removed.
Finally, the embolectomy catheter with the vein-covered balloon was
passed into the injured segment of thoracic aorta over the guide wire
(Figure 2C). Under fluoroscopic guidance, the balloon was placed at the
level of the fifth rib (Figure 1B). The wire was removed, the proximal
end of the catheter implanted in a subcutaneous pocket on the neck, the
incision closed, and the animal allowed to recover.
Four weeks after catheter placement, the balloon was firmly attached to the aortic wall and completely plaque covered in 15 of 17 animals. Six rabbits were perfusion fixed with either methacarn (methanol:chloroform:acetic acid) or 10% neutral-buffered formalin to characterize makeup of intact balloon-associated atherosclerotic lesions. Seven rabbits were used for ex vivo plaque rupture, and 2 rabbits were used for in vivo plaque rupture experiments (see below).
Plaque Rupture
Ex Vivo Experiments
Ex vivo plaque rupture was performed to measure the mechanical
strength of plaques 1 month after implantation of the vein-covered
balloons. Rabbits were anesthetized by concurrent intramuscular
injection of xylazine, ketamine, and butorphanol in doses of
7.5, 52, and 0.15 mg/kg, respectively, and then perfused with saline
via an abdominal aortic catheter to remove the blood. The thoracic
aorta was opened longitudinally, and the segment of aorta containing
the plaque was excised as 1 block with attached catheter. The aortic
segment was then pinned to a corkboard, so the plaque was fully exposed
en face. The catheter was filled with distilled water and attached to
an HPLC pump (Waters 600 Multisolvent Delivery System, Waters
Corporation). To remove air bubbles, the water was sparged with helium.
Pressure within the plaque-covered balloon was measured using a test
gauge and electronic pressure transducer. The analog signal from the
pressure transducer was both recorded on a strip chart and captured
for data analysis by an analog-to-digital converter sampling at
a rate of 250 samples per second. For each pressure measurement, the
interballoon volume was calculated as a function of time. The balloon
was inflated by infusion of water at a constant rate (0.5 mL/min) using
the HPLC pump, and the pressure within the intraplaque balloon was
increased until the plaque ruptured. The moment of visible plaque
rupture was coordinated with a sudden drop of pressure on a
recorded pressure-time curve. This pressure was considered the
"rupturing" pressure and an index of overall mechanical plaque
strength. As a control, we recorded pressure-volume curves for 5
balloons without plaques. A video camera (DXC 960 MD, Sony Corp) and
laser videodisk recorder (LVR-300N, Sony Corp) that collected 30
video frames a second were used to record balloon inflations.
Digital images were obtained using a frame grabber (LG3, Scion Corp)
and computer (model 8100, Apple Computer Inc) attached to the laser
videodisk recorder.
Procurement of Ex Vivo Ruptured Plaques for Histology
Plaque fissures often have very complex geometry and are not
always easily recognizable on the two-dimensional tissue sections.
Moreover, artificial cracks and other tissue displacements may occur
during specimen preparation. To label original irregular contours of
the plaques, we used the Davidson Marking System (Bradley
Products). This system is designed for permanent laboratory marking
of tissue in clinical pathology.12 A marking dye
is resistant to the effects of tissue fixation, processing,
embedding, and sectioning and is clearly visible in the light
microscope. Thus, after ex vivo rupture, plaques were incubated with
green tissue-marking dye for 5 minutes, blotted, washed in PBS, fixed
in methacarn and processed for histological
analysis.
In Vivo Experiments
To demonstrate the feasibility of using the model to study
consequences of plaque rupture, plaques were disrupted in vivo in 2
rabbits. Four weeks after initial placement of the indwelling catheter,
rabbits were anesthetized as described above and the port used
to inflate the balloon was exteriorized through a small surgical
incision. The intraplaque balloon was then inflated in vivo. Three
hours later, rabbits were killed, perfused with PBS, and then fixed by
perfusion with 10% neutral-buffered formalin.
Histology, Electron Microscopy, and Immunocytochemistry
To macroscopically visualize neutral lipids, formalin-fixed
samples of intact plaques were stained en block with Sudan IV. Plaques
were then cut into 3 to 4 pieces. One piece was frozen, a second
processed and paraffin embedded, and a third prepared for transmission
electron microscopy (TEM). Formalin-fixed samples of plaques ruptured
in vivo were either paraffin embedded or processed for scanning
electron microscopy (SEM). All methacarn-fixed specimens were paraffin
embedded and cut into 5-µm cross-sections.
To characterize the general architecture of the atherosclerotic
plaques, cross-sections underwent hematoxylin and eosin or Movat
pentachrome staining. Neutral lipids were visualized on frozen
sections using oil red O staining. Specimens for SEM and TEM were
prepared as previously described.13 Cellular
composition, cell proliferation, collagen synthesis, and presence of
tissue factor were characterized immunocytochemically. Primary
antibodies were as follows: an anti–smooth muscle 
-actin antibody
(Boehringer Mannheim) to identify SMCs, RAM11 (DAKO) to
identify macrophages, anti–von Willebrand factor (vWF)
(Atlantic Antibodies) to identify endothelial cells,
L11/135 (Serotec) to identify T cells, anti–type I procollagen
antibody SPI.D8 (Developmental Studies Hybridoma Bank, University of
Iowa) to visualize cells actively synthesizing type I collagen,
anti–proliferating cell nuclear antigen (PCNA) antibody PC10 (DACO) to
detect proliferating cells, monoclonal (No. 4511) and polyclonal (No.
4513) antibodies to identify tissue factor (American
Diagnostica). Standard immunoalkaline phosphatase or
immunoperoxidase techniques were applied as previously
described.14 15
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Structure of the Balloon-Associated Lesions
One month after catheter placement, the vein-wrapped balloon was firmly attached to aortic wall and completely covered with fibrotic tissue (Figure 3A
). Microscopically, the
lesion consisted of an empty core region previously occupied by the
balloon, a fibrous cap–like area that separated the empty core from
the lumen of the aorta, and a shoulder area that connected the cap with
the thickened aortic intima. Both the cap and shoulders contained
collagen-rich remnants of the vein, surrounded by newly grown tissue in
the peripheral (periluminal) part of the lesion.
Pentachrome staining revealed the presence of collagen,
elastin, and glycosaminoglycans within the plaque
(Figure 3B). Thus, the balloon-associated plaque became an integral
part of the thickened aortic intima.
|
Immunocytochemical analysis demonstrated that the plaques
contained -actin–positive SMCs, RAM11-positive macrophages,
L11/135-positive T cells, vWF-positive endothelial
cells, and some cells that did not express either of the above cell
type–specific markers. SMCs predominantly occupied the
peripheral part of the plaque (Figure 3C). The luminal
surface of the plaque was covered by endothelial cells.
In all plaques, the shoulder region consistently contained
macrophages (Figure 3D) and microvessels (Figure 3F).
Approximately 30% of the shoulder macrophages contained
numerous cytoplasmic vacuoles ("foam" cell appearance, as shown on
Figure 3E). Macrophages often formed a ring encircling the
central part of the plaque previously occupied by the balloon, and some
macrophages appeared to be multinucleated giant cells. T cells
were scattered throughout the plaque, but most colocalized with plaque
microvessels (Figure 3G). PCNA immunostaining showed
focal cell proliferation both in macrophage-rich and SMC areas
of the lesion (Figure 3H and 3I). Application of an anti–type I
procollagen antibody revealed numerous collagen-producing cells on the
periphery of the lesion, consistent with localization of SMCs
(Figure 3J and 3K).
Balloon-associated plaques accumulated neutral lipids. Lipid
accumulation occurred predominantly in the plaque shoulders (Figure 3L), while the fibrous cap area was usually spared. Lipids were
deposited both intracellularly and extracellularly. Although
intracellular lipid droplets were found in both macrophages and
SMCs, the vast majority of lipid accumulation was associated with
macrophages (data not shown).
Immunostaining with the antibodies against rabbit
tissue factor consistently demonstrated the presence of this
protein in balloon-associated lesions (Figure 3M). Tissue factor was
always found in macrophage-rich areas (Figure 3N) and often was
associated with plaque microvessels (data not shown).
The injection of surgical margin dye into the infusion port
exteriorized on the neck demonstrated successful delivery of a marker
into the space surrounding the balloon. The dye also leaked into
the periphery of plaque tissue and was uniformly distributed around the
lesion (Figure 3O).
Plaque Rupture
Balloon-associated atherosclerotic plaques were ruptured by
inflation of the balloon both in vivo and ex vivo. Our initial emphasis
has been on ex vivo rupture. This approach enables direct observation
of rupturing dynamics both spatially and temporally.
In ex vivo plaque rupture experiments, gradual balloon inflation first
led to the formation of a "hump" on the lesion surface followed by
rupture (Figure 4A through 4C). A
representative time-pressure trace obtained from a
1-month-old plaque-covered balloon is illustrated in Figure 5A. In this experiment, degassed water
was infused into the plaque-covered balloon at a constant rate (0.5
mL/min) as detailed in "Methods." Pressure within the balloon rose
from 0 to 6 atm during a 15-second infusion. When the
interplaque pressure reached 6 atm, there was a notable
inflection in the time-pressure trace. This abrupt pressure fall
coincided with the balloon opening and plaque fracture observed
visually.
|
|
The pressure-volume curve illustrated in Figure 5B is derived from the
data in Figure 5A. For each interballoon pressure (250 samples each
second), an interballoon volume was calculated. The volume was
determined as a function of time, given that the water was infused at a
constant rate. Before the plaque ruptured, a total of 140 µL of water
was infused.
The balloon itself had material properties that clearly differed from
the plaque that covered the balloon. Interballoon pressure reached a
pressure of <1 atm over a 15-second infusion (Figure 5C). Furthermore,
the balloon alone had a volume-pressure curve slope (Figure 5D) that
was very flat compared with that of the plaque-covered balloon (Figure 5B), indicating that plaque elasticity differs from that of the balloon
alone.
The rapid fall in interballoon pressure coincident with plaque fracture is a reproducible phenomenon that can be used as a "signature" of plaque rupture. We found that 1-month-old plaque-covered balloons opened at a pressure of 4.3±0.8 atm (n=6), while balloons alone opened at a significantly lower pressure of 1.3±0.1 atm (n=4). Thus, we have been able to demonstrate that the pressure needed to inflate a plaque-covered balloon differs significantly from that of a balloon alone and can be used as an end point of plaque rupture.
Future experiments are needed to determine the sensitivity of these end points to external factors and drug treatments that have been proposed to influence plaque stability. For example, it has been reported that elevated cholesterol predisposes patients to plaque rupture1 and cholesterol lowering decreases the frequency of fatal coronary events.16 17 Given these clinical observations, we have initiated studies to determine the influence of plasma cholesterol on plaque strength. Preliminary results indicate progressive plaque weakening in rabbits fed a high-cholesterol diet for 3 months, while plaque strength is maintained in rabbits fed standard chow (manuscript in preparation).
Ex vivo ruptured plaques were incubated with a surgical margin
permanent dye to label the plaque fissure sites. Areas of experimental
tissue disruption were stained green using this technique. Artificial
cracks and other tissue displacements that occurred during specimen
preparation were not stained (Figure 4D). A combination of such en
block labeling with immunostaining performed on tissue
sections provides a convenient methodology to address specific
questions about the spatial association between potential culprit
cells/molecules and ruptured (ie, the weakest) plaque regions. Figure 4E and 4F shows that rupture occurred in a macrophage-rich
shoulder area. We have observed two major patterns of spatial
association between a fissure and macrophages (Figure 4G): (1)
the fissure "snaking" among macrophages and (2) the fissure
separating a macrophage-rich area and an area containing no
macrophages. Disrupted regions were often SMC depleted (Figure 4H) or appeared to be acellular (Figure 4I).
To demonstrate the immediate consequences of plaque rupture, the
intraplaque balloon was inflated in vivo. In these experiments, rabbits
were anesthetized, the balloon inflation port was exposed
through a small incision, and the plaque was ruptured by inflation of
the balloon. Three hours after plaque rupture, the animals were killed.
Gross examination revealed the presence of concise red thrombus
covering about 15% of the plaque surface, as well as scattered
intraplaque hemorrhages (Figure 6A). Microscopic analysis proved
precise colocalization between thrombus and site of plaque rupture
(Figure 6B). The deep portion of the thrombus was directly associated
with foam cells at the edge of disrupted plaque tissue (Figure 6C),
while the luminal surface contained aggregates of platelets, red
blood cells, and a fibrin meshwork (Figure 6D).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Features of the Balloon-Associated Plaques
We have demonstrated that fibrotic lesions can be developed around an expandable balloon. Arterial lesions induced by indwelling plastic tubing have been described previously18 19 ; however, the tubing itself was not always embedded into the lesions. The critical difference between our model and models previously described is that the balloon catheter becomes an integral part of the lesion. Therefore, the behavior of the lesion may be controlled by balloon inflation and local infusion of biologically active materials into the lesion.
Importantly, the balloon-associated lesion in our model is reminiscent of human atherosclerotic plaques in terms of architecture (presence of an acellular core and a fibrous cap), cellular composition (SMCs, macrophages, T cells), growth characteristics (cell proliferation, collagen synthesis), and patterns of lipid accumulation.14 15 20 21 22 Moreover, neoangiogenesis, an important feature of advanced human lesions,23 relevant to plaque rupture,24 was observed. Neoangiogenesis has not been found previously in rabbit or smaller animal models of atherosclerosis. Our model is the only one that consistently produces plaque microvessels in a defined location. However, it should be noted that the described histological findings are typical but not necessarily specific for atherosclerotic plaques and might be interpreted as a foreign body response of the injured artery in a hyperlipemic animal.
The main feature of our model is the ability to rupture the plaque by inflation of the intraplaque balloon and thereby directly measure the mechanical characteristics of a plaque tissue. We are aware of only 1 attempt to design an animal model of plaque rupture.25 Abela et al,25 using the technique initially developed by Constantinides and Chakravarti,26 induced fibrolipid lesions in the rabbit aorta by combining mechanical injury with hypercholesterolemia and then challenged the rabbits with a combination of a proteolytic procoagulant viper venom and histamine. Although this treatment triggered thrombus formation, no associated plaque fissures were demonstrated. Furthermore, the development of suitable lesions took over eight month. In our model, advanced atherosclerotic plaques are formed in a relatively short time (1 month), plaque disruption can be easily documented, and cause-effect relationships between plaque fissuring and thrombus formation are unequivocally established.
Morphological features of disrupted lesions in our model are also suggestive of human atherosclerotic plaque in that the fissures are localized in the shoulder region,8 9 associated with the presence of macrophage1 27 28 and SMC depletion,6 29 and associated with thrombus formation after in vivo disruption.1 2 3 4 5 6
Technical Potential
Our model provides unique technical opportunities by virtue of the
fact that the "inside" of the plaque can be accessed without plaque
alterations. In our pilot studies, a dye was injected into the plaque
through a remote catheter port, providing proof of the concept
that bioactive substances may be locally delivered into the plaque.
More specific experiments are required for detailed characterization of
this local intraplaque delivery method.
We suggest that the delivery of genes, genetically modified cells, proteins, and other substances (eg, lipids) may allow for atherosclerotic plaque tissue engineering to study the influence of specific molecules or cells on plaque stability. A local drug delivery may be used to test the efficacy of compounds designed to stabilize plaques, including drugs with poor biocompatibility. Another exciting potential of the accessible intraplaque space may be the placement of various probes and arrays (eg, temperature, ultrasound) to monitor changes in plaque composition and mechanical properties after treatment. Finally, using the catheter infusion port, samples of tissue fluids may be taken to monitor secretion of various proteins during plaque formation and plaque healing after disruption.
Suggested Applications
The field of atherosclerotic plaque instability has evolved mostly
from retrospective clinical and pathological observations. There are
many hypotheses relevant to both plaque rupture pathogenesis and
treatment,2 3 6 the discussion of which is beyond
the scope of this methodological report. Our model may provide a
valuable tool to test these hypotheses under controlled experimental
conditions, as well as to generate new ones.
The focus of our model is on the mechanical properties of atherosclerotic plaques. Therefore, evaluation of breaking pressure and stress-strain relationships are viewed as the major end points. Since we have demonstrated the presence of relevant cell types (macrophages, T cells, SMCs, capillary endothelial cells), extracellular matrix components, and lipids in balloon-associated lesions, 1 strategy would be to correlate biology of these cells (invasion, proliferation, death, lipid accumulation, gene expression), balance between matrix degradation and synthesis, and tissue mechanical properties; in other words, to study "the biology of fibrous cap strength."6 Another paradigm would be to analyze the dynamics and mechanisms of thrombosis after plaque disruption, because we have documented the presence of tissue factor in experimental lesions and demonstrated thrombus formation after in vivo plaque rupture. We also hope that formation of nonocclusive thrombi after plaque disruption may serve as a tool for analysis of the rupture-related asymptomatic lesion growth suggested in angiographic and pathological human studies.30 31 32 Respectively, our model can be used to evaluate treatment strategies designed to stabilize vulnerable plaques (primary prevention), to diminish thrombosis after disruption, and to promote the healing of ruptured plaques (secondary prevention).
Animal models are essential for development of diagnostic imaging techniques.6 Although our model would not be optimal for examination of events that lead to plaque rupture, it may be helpful in accurate imaging and identification of fibrous cap fissures, as well as serial examinations of events after rupture, ie, thrombus formation and organization.
Limitations
The presence of an inflatable balloon within atherosclerotic
plaque literally comprises the core of our model, enabling plaque
"eruption," mechanical measurements, and local delivery. However,
the same feature produces limitations of the model. First, the balloon
catheter cannot be miniaturized indefinitely. Therefore, only animal
species with fairly large arteries can be used. Second, tissue
disruption by virtue of balloon inflation does not permit
analysis of specific triggers that may be clinically relevant
to plaque rupture. Development of alternative plaque-rupture models
emphasizing the triggering event would complement our model, which is
well suited to evaluate plaque mechanical properties.
Thus, we suggest that our new animal model may provide valuable information about the pathogenesis of atherosclerotic plaque rupture. It may also serve as a powerful tool in evaluating novel "plaque stabilization" treatments aiming at primary and secondary prevention of heart attack and stroke, as well as development of diagnostic imaging modalities.
Received December 1, 1997; accepted July 8, 1998.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336:1276–1282.
2.
Falk E, Shah PK, Fuster V. Coronary plaque
disruption. Circulation. 1995;92:657–671.
3.
Libby P. Molecular bases of the acute coronary
syndromes. Circulation. 1995;91:2844–2850.
4. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation. 1990;82:II-38–II-46.
5.
Davies MJ, Thomas AC. Plaque fissuring: the cause
of acute myocardial infarction, sudden ischaemic death, and crescendo
angina. Br Heart J. 1985;53:363–373.
6.
Lee RT, Libby P. The unstable atheroma.
Arterioscler Thromb Vasc Biol. 1997;17:1859–1867.
7.
Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of
fibrous cap thickness on peak circumferential stress in model
atherosclerotic vessels. Circ Res. 1992;71:850–858.
8. Richardson PD, Davies MJ, Born GV. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 1989;2:941–944.[Medline] [Order article via Infotrieve]
9.
Cheng GC, Loree HM, Kamm RD, Fishbein MC, Lee RT.
Distribution of circumferential stress in ruptured and stable
atherosclerotic lesions: a structural analysis with
histopathological correlation. Circulation. 1993;87:1179–1187.
10.
Muller JE, Kaufmann PG, Luepker RV, Weisfeldt ML,
Deedwania PC, Willerson JT. Mechanisms precipitating acute cardiac
events: review and recommendations of an NHLBI workshop. National
Heart, Lung, and Blood Institute. Mechanisms Precipitating Acute
Cardiac Events Participants. Circulation. 1997;96:3233–3239.
11. Malczak HT, Buck RC. Regeneration of endothelium in rat aorta after local freezing: a scanning electron microscopic study. Am J Pathol. 1977;86:133–148.[Abstract]
12. Parkinson AV, Cannon CR, Hayne ST. Color coding surgical margins with the Davidson marking system. J Histotechnol. 1990;13:293–294.
13. Rekhter MD, Andreeva ER, Mironov AA, Orekhov AN. Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta. Am J Pathol. 1991;138:569–580.[Abstract]
14. Rekhter MD, Gordon D. Active proliferation of different cell types, including lymphocytes, in human atherosclerotic plaques. Am J Pathol. 1995;147:668–677.[Abstract]
15. Rekhter MD, Zhang K, Narayanan AS, Phan S, Schork MA, Gordon D. Type I collagen gene expression in human atherosclerosis: localization to specific plaque regions. Am J Pathol. 1993;143:1634–1648.[Abstract]
16.
Byington RP, Jukema JW, Salonen JT, Pitt B, Bruschke
AV, Hoen H, Furberg CD, Mancini GB. Reduction in
cardiovascular events during pravastatin
therapy: pooled analysis of clinical events of the
Pravastatin Atherosclerosis Intervention
Program. Circulation. 1995;92:2419–2425.
17. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.[Medline] [Order article via Infotrieve]
18. Moore S. Thromboatherosclerosis in normolipemic rabbits: a result of continued endothelial damage. Lab Invest. 1973;29:478–487.[Medline] [Order article via Infotrieve]
19. Bocan TM, Mueller SB, Uhlendorf PD, Ferguson E, Newton RS. Dietary and mechanically induced rabbit iliac-femoral atherosclerotic lesions: a chemical and morphologic evaluation. Exp Mol Pathol. 1991;54:201–277.[Medline] [Order article via Infotrieve]
20. Rosenfeld ME, Pestel E. Cellularity of atherosclerotic lesions. Coron Artery Dis. 1994;5:189–197.[Medline] [Order article via Infotrieve]
21. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995;57:791–804.[Medline] [Order article via Infotrieve]
22.
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S,
Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A
definition of advanced types of atherosclerotic lesions and a
histological classification of
atherosclerosis: a report from the Committee on
Vascular Lesions of the Council on
Arteriosclerosis, American Heart Association.
Circulation. 1995;92:1355–1374.
23. O'Brien ER, Garvin MR, Dev R, Stewart DK, Hinohara T, Simpson JB, Schwartz SM. Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol. 1994;145:883–894.[Abstract]
24. Barger AC, Beeuwkes R III. Rupture of coronary vasa vasorum as a trigger of acute myocardial infarction. Am J Cardiol. 1990;66:41G–43G.[Medline] [Order article via Infotrieve]
25.
Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A,
Federman M, Tofler GH, Muller JE. Triggering of plaque disruption and
arterial thrombosis in an atherosclerotic rabbit model.
Circulation. 1995;91:776–784.
26. Constantinides P, Chakravarti RN. Rabbit arterial thrombosis produced by systemic procedures. Arch Pathol. 1961;72:197–208.[Medline] [Order article via Infotrieve]
27.
Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V,
Fallon JT. Macrophage infiltration in acute coronary
syndromes: implications for plaque rupture. Circulation. 1994;90:775–778.
28.
van der Wal AC, Becker AE, van der Loos CM, Das PK.
Site of intimal rupture or erosion of thrombosed coronary
atherosclerotic plaques is characterized by an inflammatory process
irrespective of the dominant plaque. Circulation. 1994;89:36–44.
29. Falk E. Why do plaques rupture? Circulation. 1992;86:III-30–III-42.
30.
Davies MJ, Bland JM, Hangartner JR, Angelini A,
Thomas AC. Factors influencing the presence or absence of acute
coronary artery thrombi in sudden ischaemic death. Eur
Heart J. 1989;10:203–208.
31. Svindland A, Torvik A. Atherosclerotic carotid disease in asymptomatic individuals: an histological study of 53 cases. Acta Neurol Scand. 1988;78:506–517.[Medline] [Order article via Infotrieve]
32.
Friedman M, Manwaring JH, Rosenman RH, Donlon G, Ortega
P, Grube SM. Instantaneous and sudden deaths: clinical and pathological
differentiation in coronary artery disease. JAMA. 1973;225:1319–1328.
This article has been cited by other articles:
 |
|
 |
|
  M Ni, W Q Chen, and Y Zhang Animal models and potential mechanisms of plaque destabilisation and disruption Heart, September 1, 2009; 95(17): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Phinikaridou, K. J. Hallock, Y. Qiao, and J. A. Hamilton A robust rabbit model of human atherosclerosis and atherothrombosis J. Lipid Res., May 1, 2009; 50(5): 787 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ni, Y. Wang, M. Zhang, P. F. Zhang, S. F. Ding, C. X. Liu, X. L. Liu, Y. X. Zhao, and Y. Zhang Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1598 - H1606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Q. Chen, L. Zhang, Y. F. Liu, L. Chen, X. P. Ji, M. Zhang, Y. X. Zhao, G. H. Yao, C. Zhang, X. L. Wang, et al. Prediction of atherosclerotic plaque ruptures with high-frequency ultrasound imaging and serum inflammatory markers Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2836 - H2844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lutgens, R.-J. van Suylen, B. C. Faber, M. J. Gijbels, P. M. Eurlings, A.-P. Bijnens, K. B. Cleutjens, S. Heeneman, and M. J.A.P. Daemen Atherosclerotic Plaque Rupture: Local or Systemic Process? Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2123 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Cullen, R. Baetta, S. Bellosta, F. Bernini, G. Chinetti, A. Cignarella, A. von Eckardstein, A. Exley, M. Goddard, M. Hofker, et al. Rupture of the Atherosclerotic Plaque: Does a Good Animal Model Exist? Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 535 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Shah Mechanisms of plaque vulnerability and rupture J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 15S - 22S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Rekhter How to evaluate plaque vulnerability in animal models of atherosclerosis? Cardiovasc Res, April 1, 2002; 54(1): 36 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Taylor, A. Bobik, M. C. Berndt, D. Ramsay, and G. Jennings Experimental Rupture of Atherosclerotic Lesions Increases Distal Vascular Resistance: A Limiting Factor to the Success of Infarct Angioplasty Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 153 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Johnstone, R. M. Botnar, A. S. Perez, R. Stewart, W. C. Quist, J. A. Hamilton, and W. J. Manning In Vivo Magnetic Resonance Imaging of Experimental Thrombosis in a Rabbit Model Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1556 - 1560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Rekhter, G. W. Hicks, D. W. Brammer, H. Hallak, E. Kindt, J. Chen, W. S. Rosebury, M. K. Anderson, P. J. Kuipers, and M. J. Ryan Hypercholesterolemia Causes Mechanical Weakening of Rabbit Atheroma : Local Collagen Loss as a Prerequisite of Plaque Rupture Circ. Res., January 7, 2000; 86(1): 101 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Rekhter Collagen synthesis in atherosclerosis: too much and not enough Cardiovasc Res, February 1, 1999; 41(2): 376 - 384. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||